Literature DB >> 30485206

The impact of adding posterior instrumentation to transpsoas lateral fusion: a systematic review and meta-analysis.

Mohammed Ali Alvi1,2, Redab Alkhataybeh1,2, Waseem Wahood1,2, Panagiotis Kerezoudis1,2, Sandy Goncalves1,2, M Hassan Murad1,2,3, Mohamad Bydon1,2.   

Abstract

OBJECTIVETranspsoas lateral interbody fusion is one of the lateral minimally invasive approaches for lumbar spine surgery. Most surgeons insert the interbody cage laterally and then insert pedicle or cortical screw and rod instrumentation posteriorly. However, standalone cages have also been used to avoid posterior instrumentation. To the best of the authors' knowledge, the literature on comparison of the two approaches is sparse.METHODSThe authors performed a systematic review and meta-analysis of the available literature on transpsoas lateral interbody fusion by an electronic search of the PubMed, EMBASE, and Scopus databases using PRISMA guidelines. They compared patients undergoing transpsoas standalone fusion (TP) with those undergoing transpsoas fusion with posterior instrumentation (TPP).RESULTSA total of 28 studies with 1462 patients were included. Three hundred and seventy-four patients underwent TPP, and 956 patients underwent TP. The mean patient age ranged from 45.7 to 68 years in the TP group, and 50 to 67.7 years in the TPP group. The incidence of reoperation was found to be higher for TP (0.08, 95% confidence interval [CI] 0.04-0.11) compared to TPP (0.03, 95% CI 0.01-0.06; p = 0.057). Similarly, the incidence of cage movement was found to be greater in TP (0.18, 95% CI 0.10-0.26) compared to TPP (0.03, 95% CI 0.00-0.05; p < 0.001). Oswestry Disability Index (ODI) and visual analog scale (VAS) scores and postoperative transient deficits were found to be comparable between the two groups.CONCLUSIONSThese results appear to suggest that addition of posterior instrumentation to transpsoas fusion is associated with decreased reoperations and cage movements. The results of previous systematic reviews and meta-analyses should be reevaluated in light of these results, which seem to suggest that higher reoperation and subsidence rates may be due to the use of the standalone technique.

Entities:  

Keywords:  GRADE = Grading of Recommendations Assessment, Development and Evaluation; ODI = Oswestry Disability Index; PRISMA = Preferred Reporting Items for Systematic Reviews and Meta-Analyses; TP = standalone transpsoas lateral lumbar interbody fusion; TPP = transpsoas lateral lumbar interbody fusion with posterior instrumentation; VAS = visual analog scale; XLIF; lumbar fusion; minimally invasive surgery; spine surgery; transpsoas

Mesh:

Year:  2018        PMID: 30485206     DOI: 10.3171/2018.7.SPINE18385

Source DB:  PubMed          Journal:  J Neurosurg Spine        ISSN: 1547-5646


  5 in total

1.  Critically Low Confidence in the Results Produced by Spine Surgery Systematic Reviews: An AMSTAR-2 Evaluation From 4 Spine Journals.

Authors:  Joseph R Dettori; Andrea C Skelly; Erika D Brodt
Journal:  Global Spine J       Date:  2020-04-13

Review 2.  Interbody Fusions in the Lumbar Spine: A Review.

Authors:  Ravi Verma; Sohrab Virk; Sheeraz Qureshi
Journal:  HSS J       Date:  2020-01-13

3.  Posterior fixation can further improve the segmental alignment of lumbar degenerative spondylolisthesis with oblique lumbar interbody fusion.

Authors:  Jingye Wu; Tenghui Ge; Ning Zhang; Jianing Li; Wei Tian; Yuqing Sun
Journal:  BMC Musculoskelet Disord       Date:  2021-02-23       Impact factor: 2.362

4.  Extreme lateral interbody fusion (XLIF) in a consecutive series of 72 patients.

Authors:  Mirza Pojskic; Benjamin Saβ; Benjamin Völlger; Christopher Nimsky; Barbara Carl
Journal:  Bosn J Basic Med Sci       Date:  2021-10-01       Impact factor: 3.363

5.  Trajectory of Lumbar Translaminar Facet Screw Under Navigation: A Cadaveric Study.

Authors:  Weerasak Singhatanadgige; Kittisak Songthong; Phattareeya Pholprajug; Wicharn Yingsakmongkol; Vit Kotheeranurak; Worawat Limthongkul
Journal:  Global Spine J       Date:  2020-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.